Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma

This study is ongoing, but not recruiting participants.

Study NCT00017290 Information provided by National Cancer Institute (NCI)

First Received: June 6, 2001 Last Updated: February 6, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Lymphoma

Additional conditions recognized in this trial

Lymphoma, Follicular
Lymphoma, Non-Hodgkin

More general conditions related to this trial

Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type

Interventions listed in this trial

keyhole limpet hemocyanin
sargramostim
cyclophosphamide
prednisone
vincristine sulfate

Additional drug interventions recognized in this trial

Immunoglobulin Idiotypes
Immunoglobulins
Keyhole-limpet hemocyanin
Vincristine

Sponsors listed in this trial

Genitope Corporation

Back to top of Main Content